Cargando…

The anti-tumor growth effect of a novel agent DMAMCL in rhabdomyosarcoma in vitro and in vivo

BACKGROUND: Rhabdomyosarcoma (RMS) is the most common soft tissue sarcoma in children with poor survival. New treatment approaches are urgently needed to improve treatment efficacy in RMS patients. DMAMCL is a novel agent from Asteraceae family that has been tested in phase I clinical trials in adul...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Ning, Hua, Zhongyan, Ba, Gen, Zhang, Simeng, Liu, Zhihui, Thiele, Carol J., Li, Zhijie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6408795/ https://www.ncbi.nlm.nih.gov/pubmed/30850026 http://dx.doi.org/10.1186/s13046-019-1107-1

Ejemplares similares

Antitumor effects of the small molecule DMAMCL in neuroblastoma via suppressing aerobic glycolysis and targeting PFKL
por: Zhang, Simeng, et al.
Publicado: (2021)

Micheliolide Derivative DMAMCL Inhibits Glioma Cell Growth In Vitro and In Vivo
por: An, Yinghong, et al.
Publicado: (2015)

The modulation of iron metabolism affects the Rhabdomyosarcoma tumor growth in vitro and in vivo
por: Asperti, Michela, et al.
Publicado: (2023)

Inhibition of STAT3 with orally active JAK inhibitor, AZD1480, decreases tumor growth in Neuroblastoma and Pediatric Sarcomas In vitro and In vivo
por: Yan, Shuang, et al.
Publicado: (2013)

Downregulation of ATXN3 Enhances the Sensitivity to AKT Inhibitors (Perifosine or MK-2206), but Decreases the Sensitivity to Chemotherapeutic Drugs (Etoposide or Cisplatin) in Neuroblastoma Cells
por: Gong, Baocheng, et al.
Publicado: (2021)

Corrigendum: Downregulation of ATXN3 enhances the sensitivity to AKT inhibitors (Perifosine or MK-2206), but decreases the sensitivity to chemotherapeutic drugs (etoposide or cisplatin) in neuroblastoma cells
por: Gong, Baocheng, et al.
Publicado: (2022)

PI3K and MAPK pathways mediate the BDNF/TrkB-increased metastasis in neuroblastoma
por: Hua, Zhongyan, et al.
Publicado: (2016)

Picropodophyllin (PPP) is a potent rhabdomyosarcoma growth inhibitor both in vitro and in vivo
por: Tarnowski, Maciej, et al.
Publicado: (2017)

Long-term every-other-day administration of DMAMCL has little effect on aging and age-associated physiological decline in mice
por: Sun, Zhaomeng, et al.
Publicado: (2019)

Dimethylaminomicheliolide (DMAMCL) Suppresses the Proliferation of Glioblastoma Cells via Targeting Pyruvate Kinase 2 (PKM2) and Rewiring Aerobic Glycolysis
por: Guo, Jianshuang, et al.
Publicado: (2019)

Combination of Rapamycin and MK-2206 Induced Cell Death via Autophagy and Necroptosis in MYCN-Amplified Neuroblastoma Cell Lines
por: Dong, Yudi, et al.
Publicado: (2020)

The Novel Tubulin Polymerization Inhibitor MHPT Exhibits Selective Anti-Tumor Activity against Rhabdomyosarcoma In Vitro and In Vivo
por: Mu, Yan, et al.
Publicado: (2015)

Proteome and Acetylome Analysis Identifies Novel Pathways and Targets Regulated by Perifosine in Neuroblastoma
por: Gu, Xiao, et al.
Publicado: (2017)

ROS generation and autophagosome accumulation contribute to the DMAMCL-induced inhibition of glioma cell proliferation by regulating the ROS/MAPK signaling pathway and suppressing the Akt/mTOR signaling pathway
por: Wang, Yanjun, et al.
Publicado: (2019)

Prioritization of Novel Agents for Patients with Rhabdomyosarcoma: A Report from the Children’s Oncology Group (COG) New Agents for Rhabdomyosarcoma Task Force
por: Pacenta, Holly L., et al.
Publicado: (2021)

Phosphocaveolin-1 Enforces Tumor Growth and Chemoresistance in Rhabdomyosarcoma
por: Faggi, Fiorella, et al.
Publicado: (2014)

Myogenetic Oligodeoxynucleotides as Anti-Nucleolin Aptamers Inhibit the Growth of Embryonal Rhabdomyosarcoma Cells
por: Nohira, Naoki, et al.
Publicado: (2022)

HSDL2 Promotes Bladder Cancer Growth In Vitro and In Vivo
por: Jia, Ling-Hua, et al.
Publicado: (2019)

In vitro and in vivo profiling of P-glycoprotein in human neuroblastoma and rhabdomyosarcoma cells under simvastatin exposure
por: Sieczkowski, Evelyn, et al.
Publicado: (2009)

In Vitro, In Silico and In Vivo Studies of Ursolic Acid as an Anti-Filarial Agent
por: Kalani, Komal, et al.
Publicado: (2014)

SRC family kinase (SFK) inhibition reduces rhabdomyosarcoma cell growth in vitro and in vivo and triggers p38 MAP kinase-mediated differentiation
por: Casini, Nadia, et al.
Publicado: (2015)

CASZ1 induces skeletal muscle and rhabdomyosarcoma differentiation through a feed-forward loop with MYOD and MYOG
por: Liu, Zhihui, et al.
Publicado: (2020)

Synthesis, in vitro and in vivo biological evaluation of novel lappaconitine derivatives as potential anti-inflammatory agents
por: Pang, Lei, et al.
Publicado: (2020)

Effect of inhibition of the Ubiquitin-Proteasome System and Hsp90 on growth and survival of Rhabdomyosarcoma cells in vitro
por: Peron, Marica, et al.
Publicado: (2012)

Anti-tumour activity in vitro and in vivo of selective differentiating agents containing hydroxamate
por: Qiu, L, et al.
Publicado: (1999)

The Novel Analogue of Hirsutine as an Anti-Hypertension and Vasodilatary Agent Both In Vitro and In Vivo
por: Zhu, Kai, et al.
Publicado: (2015)

In vivo emergence of a highly metastatic tumour cell line from a rat rhabdomyosarcoma after treatment with an alkylating agent.
por: Antoine, E., et al.
Publicado: (1988)

Myogenic regulatory transcription factors regulate growth in rhabdomyosarcoma
por: Tenente, Inês M, et al.
Publicado: (2017)

HNRNPH1 is required for rhabdomyosarcoma cell growth and survival
por: Li, Yanfeng, et al.
Publicado: (2018)

Caveolin-1 is down-regulated in alveolar rhabdomyosarcomas and negatively regulates tumor growth
por: Huertas-Martínez, Juan, et al.
Publicado: (2014)

CASZ1b, the Short Isoform of CASZ1 Gene, Coexpresses with CASZ1a during Neurogenesis and Suppresses Neuroblastoma Cell Growth
por: Liu, Zhihui, et al.
Publicado: (2011)

Dickkopf-1 Inhibition Reactivates Wnt/β-Catenin Signaling in Rhabdomyosarcoma, Induces Myogenic Markers In Vitro and Impairs Tumor Cell Survival In Vivo
por: Giralt, Irina, et al.
Publicado: (2021)

Caveolins in rhabdomyosarcoma
por: Rossi, Stefania, et al.
Publicado: (2011)

Relapsed Rhabdomyosarcoma
por: Heske, Christine M., et al.
Publicado: (2021)

Human Rhabdomyosarcoma Cell Lines for Rhabdomyosarcoma Research: Utility and Pitfalls
por: Hinson, Ashley R. P., et al.
Publicado: (2013)

MiR-223 Exclusively Impairs In Vitro Tumor Growth through IGF1R Modulation in Rhabdomyosarcoma of Adolescents and Young Adults
por: Casanova, Michela, et al.
Publicado: (2022)

Combination therapy of doxorubicin and Sildenafil inhibits the growth of pediatric rhabdomyosarcoma
por: Urla, Cristian, et al.
Publicado: (2022)

Comparison of (18)F-FDG PET/CT and (68)Ga-FAPI in Spindle Cell Rhabdomyosarcoma
por: Shen, Zhihui, et al.
Publicado: (2023)

Botryoid Rhabdomyosarcoma of the Conjunctiva in a Young Boy
por: Pennington, Justin D., et al.
Publicado: (2018)

Development and Use a Novel combined in-vivo and in-vitro Assay for Anti-inflammatory and Immunosuppressive Agents
por: Li, Tan, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_7moou6mvv8urone20mdf1otcus